Title
Development of screening inventories for bipolar disorder at workplace: A diagnostic accuracy study
Date Issued
01 June 2015
Access level
metadata only access
Resource Type
research article
Author(s)
Imamura K.
Kawakami N.
Naganuma Y.
Igarashi Y.
Abstract
Background: This study aimed to develop a new instrument for bipolar disorder screening, the Workplace Bipolar Inventory (WBI), and examine its efficiency as compared with Mood Disorder Questionnaire (MDQ) and Bipolar Spectrum Diagnostic Scale (BSDS) among workers on leave of the absence due to their mental health problems. Methods: Participants were recruited at a psychiatric outpatient clinic for return-to-work in Tokyo, Japan, during September to November 2009. 81 outpatients were recruited, 55 of whom (68%) agreed to participate in this study. Participants answered questionnaires including WBI, MDQ, BSDS, and demographic factors. Their diagnostic information according to the international statistical classification of diseases and related health problems 10th revision (ICD-10) was obtained from their attending psychiatrists. The WBI is a new self-rating 39-item questionnaire which developed with input from occupational mental health specialists and an analysis of WHO Composite International Diagnostic Interview (CIDI) items. The WBI contains 3 subtype scales: WBI-A (5 items), WBI-AB4 (9 items), and WBI-AB (39 items). Results: Reliability of these scales was moderate. In the AUC of these scales, BSDS was the best of them (0.83). In the optimal cut-off point of these scales, WBI-AB4 showed good efficiency of screening (sensitivity=0.78, specificity=0.75). Both MDQ and BSDS had high specificity, while low in sensitivity. Limitations: The well validated diagnostic method (i.e., the structured clinical interview for DSM-IV [SCID] or CIDI) was not applied in this study. Conclusions: The WBI, especially WBI-AB4 would be a useful workplace screening tool for workers with bipolar disorder.
Start page
32
End page
38
Volume
178
Language
English
OCDE Knowledge area
Psiquiatría
Subjects
Scopus EID
2-s2.0-84924978230
PubMed ID
Source
Journal of Affective Disorders
ISSN of the container
01650327
Sponsor(s)
The present study was supported by the Health and Labour Sciences Research Grants, Research on Psychiatric and Neurological Diseases and Mental Health, from the Japan Ministry of Health, Labour and Welfare. The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The authors had access to the data in the study and the final responsibility to submit the paper.
NK has received honoraria for speaking at CME meetings sponsored by GlaxoSmithKline, Eizai and Pfizer. He is on the advisory board for Sekisui Chemicals and Junpukai Health Care Center. He has received royalties from Chuo-Hoki-Shuppan, Igaku-Shoin, Kyobun-do, Life Science, Maruzen, Nanko-do, Nanzan-do, and Fujitsu Software Technologies, Ltd., and research grants from Fujitsu Software Technologies, Ltd., Softbank, Co., Ltd., and Japan Management Association.
Sources of information:
Directorio de Producción Científica
Scopus